ICLR

ICLR

USD

ICON plc Ordinary Shares

$146.690+2.270 (1.572%)

即時價格

Healthcare
Diagnostics & Research
愛爾蘭

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$144.420

最高

$148.310

最低

$142.640

交易量

1.28M

公司基本面

市值

11.7B

行業

Diagnostics & Research

國家

Ireland

交易統計

平均交易量

1.49M

交易所

NMS

貨幣

USD

52週範圍

最低 $125.1當前 $146.690最高 $347.72

相關新聞

PR Newswire

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company...

查看更多
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
PR Newswire

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company...

查看更多
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
BusinessWire

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

ICON plc, (NASDAQ:ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair 45th Annual Growth

查看更多
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference
PR Newswire

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company...

查看更多
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
BusinessWire

ICON releases its ICON Cares 2024 Report

ICON plc, (NASDAQ:ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how the company is delivering on its

查看更多
ICON releases its ICON Cares 2024 Report
PR Newswire

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company...

Analyst Upgrades

Mizuho Maintains Outperform on Icon, Lowers Price Target to $173

Mizuho analyst Ann Hynes maintains Icon with a Outperform and lowers the price target from $200 to $173.